GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » EV-to-Revenue

Cresco Labs (Cresco Labs) EV-to-Revenue : 1.73 (As of May. 17, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cresco Labs's enterprise value is $1,334.2 Mil. Cresco Labs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $770.9 Mil. Therefore, Cresco Labs's EV-to-Revenue for today is 1.73.

The historical rank and industry rank for Cresco Labs's EV-to-Revenue or its related term are showing as below:

CRLBF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.04   Med: 3.48   Max: 76.3
Current: 1.73

During the past 13 years, the highest EV-to-Revenue of Cresco Labs was 76.30. The lowest was 1.04. And the median was 3.48.

CRLBF's EV-to-Revenue is ranked better than
62.77% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.415 vs CRLBF: 1.73

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-17), Cresco Labs's stock price is $2.16. Cresco Labs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.39. Therefore, Cresco Labs's PS Ratio for today is 0.90.


Cresco Labs EV-to-Revenue Historical Data

The historical data trend for Cresco Labs's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs EV-to-Revenue Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.35 5.31 2.86 1.25 1.24

Cresco Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.25 1.28 1.25 1.51 1.24

Competitive Comparison of Cresco Labs's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cresco Labs's EV-to-Revenue falls into.



Cresco Labs EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cresco Labs's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1334.235/770.885
=1.73

Cresco Labs's current Enterprise Value is $1,334.2 Mil.
Cresco Labs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $770.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs  (OTCPK:CRLBF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cresco Labs's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.16/2.388
=0.90

Cresco Labs's share price for today is $2.16.
Cresco Labs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.39.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cresco Labs's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (Cresco Labs) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.